SHANNON ROSINE: Open Payments
NPI 1659520351 · ARLINGTON HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Amgen Inc. | 3 | $53 |
| Novo Nordisk Inc | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| ABBVIE INC. | 2 | $30 |
| Boston Scientific Corporation | 1 | $25 |
| PFIZER INC. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
Products named: Auvelity, FARXIGA, VRAYLAR, Wegovy, Bulkamid, KRYSTEXXA, NURTEC ODT, CAPLYTA.
Industry payments across IL — which companies pay providers there.
